Migraine patients often suffer a long time before docs zero in on the best dosage for drugs designed to prevent thei ...

ALAFIA AI's supercomputer accelerates AI workflows in healthcare, reducing task times from 30-60 minutes to under 30 seconds.

Doctors conducted suicide risk assessments for 42% of patients flagged by interruptive alerts, compared with only 4% with ...

The mentorship culture at Duke-NUS Medical School empowers students with the knowledge and confidence to thrive from ...

The transaction adds global rights to Zealmy, a commercial-stage rare neurology medicine approved by FDA, the European Commission, the UK Medicines and Healthcare products Regulatory Agency and ...

The formation of Gain’s new Clinical Advisory Board marks a significant strategic step forward for Gain, as GT-02287 advances into Parkinson’s disease patients,” stated Gene Mack, CEO of Gain ...

Transaction rationale and details in brief: Adds global rights to ZTALMY, a commercial-stage rare neurology medicine approved by FDA, the European Commission (EC), the UK Medicines and Healthcare ...

The acquisition grants Immedica global rights to ZTALMY, a commercial-stage rare neurology medicine approved by the FDA, European Commission, UK MHRA, and China’s NMPA, with potential for ...